5.03
+0.09(+1.82%)
Currency In USD
| Previous Close | 4.94 |
| Open | 4.95 |
| Day High | 5.09 |
| Day Low | 4.85 |
| 52-Week High | 16.65 |
| 52-Week Low | 3.78 |
| Volume | 183,747 |
| Average Volume | 285,103 |
| Market Cap | 92.66M |
| PE | -3.75 |
| EPS | -1.34 |
| Moving Average 50 Days | 5.33 |
| Moving Average 200 Days | 8.8 |
| Change | 0.09 |
If you invested $1000 in OptimizeRx Corporation (OPRX) 10 years ago, it would be worth $1,612.18 as of December 26, 2024 at a share price of $5.03. Whereas If you bought $1000 worth of OptimizeRx Corporation (OPRX) shares 5 years ago, it would be worth $492.17 as of December 26, 2024 at a share price of $5.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
GlobeNewswire Inc.
Dec 23, 2024 1:45 PM GMT
WALTHAM, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,
OptimizeRx to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 18, 2024 12:30 PM GMT
WALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, t
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
GlobeNewswire Inc.
Oct 31, 2024 11:30 AM GMT
WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, w